Kazantseva, Marina <br/><br/>
Elevation of the TP53 isoform Δ133p53β in glioblastomas: an alternative to mutant p53 in promoting tumor development.  [electronic resource] 

 -  The Journal of pathology  09 2018 
 - 77-88 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-9896 
<br/><br/><label>Standard No.: </label>10.1002/path.5111  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, CD--metabolism<br/>Antigens, Differentiation, Myelomonocytic--metabolism<br/>Antineoplastic Agents, Alkylating--pharmacology<br/>B7-H1 Antigen--metabolism<br/>Biomarkers, Tumor--genetics<br/>Brain Neoplasms--drug therapy<br/>Cell Line<br/>Chemokine CCL2--metabolism<br/>Drug Resistance, Neoplasm<br/>Gene Expression Regulation, Neoplastic<br/>Glioblastoma--drug therapy<br/>Humans<br/>Macrophages--metabolism<br/>Mice<br/>Mutation<br/>Oxidative Stress<br/>Protein Isoforms<br/>Receptors, Cell Surface--metabolism<br/>Receptors, Granulocyte-Macrophage Colony-Stimulating Factor--metabolism<br/>Signal Transduction<br/>Temozolomide--pharmacology<br/>Tumor Hypoxia<br/>Tumor Microenvironment<br/>Tumor Suppressor Protein p53--genetics<br/>Up-Regulation<br/>CD163 Antigen